Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesThe SLIM study: Slo-Niacin and atorvastatin treatment of lipoproteins and inflammatory markers in combined hyperlipidemia
Journal of Clinical Lipidology, 06/24/09
Knopp RH et al. – Nonprescription time-release niacin (Slo-Niacin) 1.5 g/day with atorvastatin 10 mg/day improved lipoprotein lipids, apoproteins, and inflammation markers without hepatotoxicity, pending further study as a cost-effective treatment of hyperlipidemia.
Methods- Study of Slo-Niacin and atorvastatin, singly and together, to determine efficacy for combined abnormalities of triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C)
- Subjetcs: 42 men and women with LDL-C >130 mg/dL and HDL-C <45 mg/dL (men) or <55 mg/dL (women)
- Randomization to 3 mo of atorvastatin 10 mg/d or incremental doses of Slo-Niacin to 1500 mg/d
- Addition of alternate drug in next 3-mo segment
- Measurement of lipid profiles and transaminases monthly
- Other measures at baseline and end of each treatment sequence
- Mean entry lipids (in mg/dL) follows: TG 187, LDL-C 171, and HDL-C 39
- Mean body mass index: 32.6kg/m2
- Slo-Niacin monotherapy decreased median TG 15%, mean LDL-C 12%, and non-HDL-C 15% and increased HDL-C 8%
- Atorvastatin decreased median TG 26%, mean LDL-C 36%, and non-HDL-C 36% and increased HDL-C 6%
- Combined therapy decreased median TG 33% and mean LDL-C and non-HDL-C each 43%. HDL-C increased 10%
- Median remnant-like lipoprotein-C decreased 55%, mean apo-B 40%, median high-sensitivity C-reactive protein 23%, tumor necrosis factor alpha 12%, and no change in interleukin-6
- Mean LDL buoyancy increased 15%, apo-A-I 5%, and median HDL2-C 20%
- ALT decreased with Slo-Niacin treatment alone vs atorvastatin and decreased with Slo-Niacin added to atorvastatin
- Study discontinuation by 6 subjects, 3 due to niacin-related symptoms
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Interleukin-18 levels are associated with low-density lipoproteins size
European Journal of Clinical Investigation, 12/04/09
Is Moderate Atherosclerotic Stenosis in the Middle Cerebral Artery a Cause of or a Coincidental Finding in Ischemic Stroke
Cerebrovascular Diseases, 12/04/09
Small, dense LDL cholesterol and apolipoprotein B: Relationship with serum lipids and LDL size
Atherosclerosis, 12/04/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study
Journal of Dermatological Treatment , 12/04/09
Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: A randomized clinical study
Journal of Dermatological Treatment , 12/04/09
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders
Journal of Dermatological Treatment , 12/04/09
Sponsor
Article Search
Sponsor
Sponsor